Dare
to be Different

We are accelerating improved treatment options in women’s health.

Dare
Different

Women’s health innovations are often not the priority, and for Daré, that’s not ok.

We are working hard to identify and advance new therapies that provide additional choices, enhanced outcomes and ease of use for women. By developing and bringing these products to market, we plan to make a difference in the lives of women worldwide.

Our Mission
OurVision

To become the coordinating presence in women’s health. We achieve this by identifying, unlocking and advancing innovation that improves health outcomes and promotes a better quality of life for women.

Daré
In Italian, it means to give.
In English, it means to be bold.

To us, Daré means to give women novel treatment options by boldly addressing existing therapeutic gaps. And that’s exactly our mission.

To become the coordinating presence in women’s health. We achieve this by identifying, unlocking and advancing innovation that improves health outcomes and promotes a better quality of life for women.

Daré
In Italian, it means to give.
In English, it means to be bold.

To us, Daré means to give women novel treatment options by boldly addressing existing therapeutic gaps. And that’s exactly our mission.

Our

Approach

We are accelerating innovation in women’s health

At Daré, we believe women’s health is an important therapeutic area that deserves dramatically increased attention, investment and innovation.

Some of the most persistent unmet needs in women’s health are not yet solved simply because companies have not taken the time to address them. We are the premier partner in women’s health working to address these problems head on, utilizing a novel innovation acceleration model that we believe enables us to identify and advance product candidates more efficiently than traditional R&D driven organizations.

Innovation does not have to start from scratch. The product candidates we identify, in many cases, already have a successful proof of concept study or an established safety profile for the active ingredient that we can leverage in the development process.

We advance the most promising therapies and look to partner our programs at mid or later-stages of development with companies in women’s health that share our commitment to expand options and improve outcomes for women.

Move the

field forward

Our expertise spans therapeutics, devices and diagnostics, and we have ample experience in fundraising, clinical and regulatory strategy and implementation, partnering and commercial product launches with established pharmaceutical partners. Through the clinical development and commercialization of novel products, we’re working to advance women’s healthcare globally.

Executive Team

Sabrina Martucci Johnson

President and Chief Executive Officer

Lisa Walters-Hoffert

Chief Financial Officer

David Friend, PhD

Chief Scientific Officer

John Fair

Chief Business Officer

Mary Jarosz, RPh, RAC FTOPRA

Global Head of Regulatory Affairs

Mark Walters

Vice President, Operations

Christine Mauck, MD

Medical Director

Board of Directors

William H. Rastetter, PhD

Chairman of The Board

Sabrina Martucci Johnson

President and Chief Executive Officer